Aqr Capital Management LLC Voyager Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

A detailed history of Aqr Capital Management LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 248,623 shares of VYGR stock, worth $1.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

248,623

Previous 502,375 50.51%

Holding current value

$1.44 Million

Previous $3.97 Million 63.4%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.77 - $9.27 $1.46 Million - $2.35 Million	-253,752 Reduced 50.51%	248,623 $1.45 Million
Q2 2024 Aug 14, 2024	SELL	$7.42 - $10.54 $2.16 Million - $3.07 Million	-291,259 Reduced 36.7%	502,375 $3.97 Million
Q1 2024 May 15, 2024	BUY	$7.15 - $10.84 $1.1 Million - $1.67 Million	154,347 Added 24.14%	793,634 $7.39 Million
Q4 2023 Feb 14, 2024	BUY	$6.28 - $8.81 $2.77 Million - $3.88 Million	440,465 Added 221.54%	639,287 $5.4 Million
Q3 2023 Nov 14, 2023	BUY	$7.55 - $11.25 $1.5 Million - $2.24 Million	198,822 New	198,822 $1.54 Million
Q3 2021 Nov 15, 2021	SELL	$2.63 - $4.12 $437,447 - $685,279	-166,330 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.94 - $5.44 $772,665 - $1.07 Million	-196,108 Reduced 54.11%	166,330 $687,000
Q1 2021 May 17, 2021	BUY	$4.61 - $9.04 $899,332 - $1.76 Million	195,083 Added 116.57%	362,438 $1.71 Million
Q4 2020 Feb 16, 2021	BUY	$7.15 - $12.28 $1.01 Million - $1.74 Million	141,435 Added 545.66%	167,355 $1.2 Million
Q3 2020 Nov 16, 2020	SELL	$10.01 - $13.75 $256,696 - $352,605	-25,644 Reduced 49.73%	25,920 $277,000
Q2 2020 Aug 17, 2020	SELL	$8.05 - $14.21 $56,076 - $98,986	-6,966 Reduced 11.9%	51,564 $651,000
Q1 2020 May 15, 2020	SELL	$6.8 - $14.66 $81,096 - $174,835	-11,926 Reduced 16.93%	58,530 $536,000
Q4 2019 Feb 14, 2020	SELL	$12.82 - $16.85 $95,496 - $125,515	-7,449 Reduced 9.56%	70,456 $983,000
Q3 2019 Nov 14, 2019	BUY	$16.31 - $28.29 $934,546 - $1.62 Million	57,299 Added 278.07%	77,905 $1.34 Million
Q2 2019 Aug 14, 2019	SELL	$19.18 - $27.88 $77,851 - $113,164	-4,059 Reduced 16.46%	20,606 $561,000
Q1 2019 May 14, 2019	SELL	$8.0 - $19.66 $199,392 - $490,005	-24,924 Reduced 50.26%	24,665 $472,000
Q4 2018 Feb 14, 2019	BUY	$8.59 - $18.05 $262,922 - $552,474	30,608 Added 161.26%	49,589 $466,000
Q3 2018 Nov 15, 2018	SELL	$17.11 - $21.74 $74,360 - $94,482	-4,346 Reduced 18.63%	18,981 $359,000
Q2 2018 Aug 14, 2018	BUY	$16.76 - $23.92 $390,960 - $557,981	23,327 New	23,327 $456,000

Others Institutions Holding VYGR

# of Institutions

130

Shares Held

34.7M

Call Options Held

39.7K

Put Options Held

34.6K

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Voyager Therapeutics, Inc. Transaction History